Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested

DNA and Cell Biology

Volumn 27, Issue 12, 2008, Pages 637-648

  Chou, Ping Jen ^a   Newton, Catherine A ^a   Perkins, Izabella ^a   Friedman, Herman ^a   Klein, Thomas W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; GLYCOPROTEIN P 15095;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; IMMUNOMODULATION; LEGIONELLA PNEUMOPHILA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DRUG COMBINATIONS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; IMMUNOLOGIC TECHNIQUES; LEGIONNAIRES' DISEASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

BACILLUS ANTHRACIS; LEGIONELLA PNEUMOPHILA; MUS;

EID: 57149088455     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0760     Document Type: Article

References (62)

1. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, Quinn C, and Pulendran B. (2003). Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424, 329-334.
2. Alileche A, Serfass ER, Muehlbauer SM, Porcelli SA, and Brojatsch J. (2005). Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathog 1, e19.
3. Alli OA, Gao LY, Pedersen LL, Zink S, Radulic M, Doric M, and Abu Kwaik Y. (2000). Temporal pore formation-mediated egress from macrophages and alveolar epithelial cells by Legionella pneumophila. Infect Immun 68, 6431-6440.
4. Atlas RM. (2002). Bioterriorism: from threat to reality. Annu Rev Microbiol 56, 167-185.
5. Baldari CT, Tonello F, Paccani SR, and Montecucco C. (2006). Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol 27, 434-440.
6. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, and Palucka K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811.
7. Bergman NH, Passalacqua KD, Gaspard R, Shetron-Rama LM, Quackenbush J, and Hanna PC. (2005). Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication. Infect Immun 73, 1069-1080.
8. Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA, Young HA, Anderson AO, and Bavari S. (2005). Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol 174, 5545-5552.
9. Byrne B and Swanson MS. (1998). Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect Immun 66, 3029-3034.
10. Cleret A, Quesnel-Hellmann A, Mathieu J, Vidal D, and Tournier JN. (2006). Resident CD11c + lung cells are impaired by anthrax toxins after spore infection. J Infect Dis 194, 86-94.
11. Collier RJ and Young JA. (2003). Anthrax toxin. Annu Rev Cell Dev Biol 19, 45-70.
12. Comer JE, Chopra AK, Peterson JW, and Konig R. (2005). Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun 73, 8275-8281.
13. Cui X, Li Y, Li X, Haley M, Moayeri M, Fitz Y, Leppla SH, and Eichacker PQ. (2006). Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival. J Infect Dis 193, 829-840.
14. Cui X, Li Y, Li X, Laird MW, Subramanian M, Moayeri M, Leppla SH, Fitz Y, Su J, Sherer K, and Eichacker PQ. (2007). Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis 195, 572-580.
15. Dixon TC, Meselson M, Guillemin J, and Hanna PC. (1999). Anthrax. N Engl J Med 341, 815-826.
16. Drum CL, Yan SZ, Bard J, Shen YQ, Lu D, Soelaiman S, Grabarek Z, Bohm A, and Tang WJ. (2002). Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415, 396-402.
17. Duesbery NS and Vande Woude GF. (1999). Anthrax toxins. Cell Mol Life Sci 55, 1599-1609.
18. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, and Vande Woude GF. (1998). Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280, 734-737.
19. During RL, Li W, Hao B, Koenig JM, Stephens DS, Quinn CP, and Southwick FS. (2005). Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis 192, 837-845.
20. Erwin JL, DaSilva LM, Bavari S, Little SF, Friedlander AM, and Chanh TC. (2001). Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun 69, 1175-1177.
21. Fang H, Cordoba-Rodriguez R, Lankford CS, and Frucht DM. (2005). Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4 + T cells. J Immunol 174, 4966-4971.
22. Fang H, Xu L, Chen TY, Cyr JM, and Frucht DM. (2006). Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J Immunol 176, 6155-6161.
23. Firoved AM, Miller GF, Moayeri M, Kakkar R, Shen Y, Wiggins JF, McNally EM, Tang WJ, and Leppla SH. (2005). Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol 167, 1309-1320.
24. Friedlander AM, Bhatnagar R, Leppla SH, Johnson L, and Singh Y. (1993). Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect Immun 61, 245-252.
25. Friedman H, Yamamoto Y, and Klein TW. (2002). Legionella pneumophila pathogenesis and immunity. Semin Pediatr Infect Dis 13, 273-279.
26. He J, Gurunathan S, Iwasaki A, Ash-Shaheed B, and Kelsall BL. (2000). Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J Exp Med 191, 1605-1610.
27. Hoover DL, Friedlander AM, Rogers LC, Yoon IK, Warren RL, and Cross AS. (1994). Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun 62, 4432-4439.
28. Husmann LK and Johnson W. (1994). Cytotoxicity of extracellular Legionella pneumophila. Infect Immun 62, 2111-2114.
29. Kambayashi T, Wallin RP, and Ljunggren HG. (2001). cAMP-elevating agents suppress dendritic cell function. J Leukoc Biol 70, 903-910.
30. Kassam A, Der SD, and Mogridge J. (2005). Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell Microbiol 7, 281-292.
31. Kikuchi T, Kobayashi T, Gomi K, Suzuki T, Tokue Y, Watanabe A, and Nukiwa T. (2004). Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses. J Immunol 172, 1727-1734.
32. Kikuchi T, Andarini S, Xin H, Gomi K, Tokue Y, Saijo Y, Honjo T, Watanabe A, and Nukiwa T. (2005). Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila. Infect Immun 73, 5350-5357.
33. Kirby JE, Vogel JP, Andrews HL, and Isberg RR. (1998). Evidence for pore-forming ability by Legionella pneumophila. Mol Microbiol 27, 323-336.
34. Leppla SH. (1982). Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 79, 3162-3166.
35. Liu YJ. (2001). Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-262.
36. Lu T, Newton C, Perkins I, Friedman H, and Klein TW. (2006a). Role of cannabinoid receptors in delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. Eur J Pharmacol 532, 170-177.
37. Lu T, Newton C, Perkins I, Friedman H, and Klein TW. (2006b). Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J Pharmacol Exp Ther 319, 269-276.
38. McAllister RD, Singh Y, du Bois WD, Potter M, Boehm T, Meeker ND, Fillmore PD, Anderson LM, Poynter ME, and Teuscher C. (2003). Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. Am J Pathol 163, 1735-1741.
39. Moayeri M, Haines D, Young HA, and Leppla SH. (2003). Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 112, 670-682.
40. Moayeri M, Martinez NW, Wiggins J, Young HA, and Leppla SH. (2004). Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect Immun 72, 4439-4447.
41. Mock M and Fouet A. (2001). Anthrax. Annu Rev Microbiol 55, 647-671.
42. Mourez M. (2004). Anthrax toxins. Rev Physiol Biochem Pharmacol 152, 135-164.
43. Neild AL and Roy CR. (2003). Legionella reveal dendritic cell functions that facilitate selection of antigens for MHC class II presentation. Immunity 18, 813-823.
44. Neumeister B, Faigle M, Lauber K, Northoff H, and Wesselborg S. (2002). Legionella pneumophila induces apoptosis via the mitochondrial death pathway. Microbiology 148, 3639-3650.
45. Newton CA, Perkins I, Widen RH, Friedman H, and Klein TW. (2007). Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice. Infect Immun 75, 146-151.
46. O'Brien J, Friedlander A, Dreier T, Ezzell J, and Leppla S. (1985). Effects of anthrax toxin components on human neutrophils. Infect Immun 47, 306-310.
47. Paccani SR, Tonello F, Ghittoni R, Natale M, Muraro L, D'Elios MM, Tang WJ, Montecucco C, and Baldari CT. (2005). Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med 201, 325-331.
48. Park JM, Greten FR, Li ZW, and Karin M. (2002). Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297, 2048-2051.
49. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, and Montecucco C. (1999). Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett 462, 199-204.
50. Pezard C, Berche P, and Mock M. (1991). Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59, 3472-3477.
51. Pezard C, Weber M, Sirard JC, Berche P, and Mock M. (1995). Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun 63, 1369-1372.
52. Pulendran B, Palucka K, and Banchereau J. (2001). Sensing pathogens and tuning immune responses. Science 293, 253-256.
53. Reig N, Jiang A, Couture R, Sutterwala FS, Ogura Y, Flavell RA, Mellman I, and van der Goot FG. (2008). Maturation modulates caspase-1-independent responses of dendritic cells to anthrax lethal toxin. Cell Microbiol 10, 1190-1207.
54. Rogers J, Hakki A, Perkins I, Newton C, Widen R, Burdash N, Klein T, and Friedman H. (2007). Legionella pneumophila infection up-regulates dendritic cell Toll-like receptor 2 (TLR2)/TLR4 expression and key maturation markers. Infect Immun 75, 3205-3208.
55. Shortman K and Liu YJ. (2002). Mouse and human dendritic cell subtypes. Nat Rev Immunol 2, 151-161.
56. Starnbach MN and Collier RJ. (2003). Anthrax delivers a lethal blow to host immunity. Nat Med 9, 996-997.
57. Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, Mock M, Vidal DR, and Goossens PL. (2005). Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174, 4934-4941.
58. Vitale G, Bernardi L, Napolitani G, Mock M, and Montecucco C. (2000). Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352 Pt 3, 739-745.
59. Voth DE, Hamm EE, Nguyen LG, Tucker AE, Salles, II, Ortiz-Leduc W, and Ballard JD. (2005). Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell Microbiol 7, 1139-1149.
60. Watters JW, Dewar K, Lehoczky J, Boyartchuk V, and Dietrich WF. (2001). Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Curr Biol 11, 1503-1511.
61. Wright GG and Mandell GL. (1986). Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J Exp Med 164, 1700-1709.
62. Zink SD, Pedersen L, Cianciotto NP, and Abu-Kwaik Y. (2002). The Dot/Icm type IV secretion system of Legionella pneumophila is essential for the induction of apoptosis in human macrophages. Infect Immun 70, 1657-1663.